Shortened Length of Stay Improves Financial Outcomes in Living Donor Kidney Transplantation

 

 Buy Article Permissions and Reprints

Abstract

Kidney transplantation is the preferred clinical and most cost-effective option for end-stage renal disease. Significant advances have taken place in the care of the transplant patients with improvements in clinical outcomes. The optimization of the costs of transplantation has been a constant goal as well. We present herein the impact in financial outcomes of a shortened length of stay after kidney transplant.

• References

• 1 Wolfe RA, Ashby VB, Milford EL , et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341 (23) 1725-1730
  CrossrefPubMedGoogle Scholar
• 2 Merion RM, Ashby VB, Wolfe RA , et al. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294 (21) 2726-2733
  CrossrefPubMedGoogle Scholar
• 3 Laupacis A, Keown P, Pus N , et al. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50 (1) 235-242
  CrossrefPubMedGoogle Scholar
• 4 U.S. Renal Data Systems. USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2011
  Google Scholar
• 5 Menzin J, Lines LM, Weiner DE , et al. A review of the costs and cost effectiveness of interventions in chronic kidney disease: implications for policy. Pharmacoeconomics 2011; 29 (10) 839-861
  CrossrefPubMedGoogle Scholar
• 6 Evans RW, Kitzmann DJ. An economic analysis of kidney transplantation. Surg Clin North Am 1998; 78 (1) 149-174
  CrossrefPubMedGoogle Scholar
• 7 Klarenbach S, Barnieh L, Gill J. Is living kidney donation the answer to the economic problem of end-stage renal disease?. Semin Nephrol 2009; 29 (5) 533-538
  CrossrefPubMedGoogle Scholar
• 8 Schweitzer EJ, Wiland A, Evans D , et al. The shrinking renal replacement therapy “break-even” point. Transplantation 1998; 66 (12) 1702-1708
  CrossrefPubMedGoogle Scholar
• 9 Mullins CD, Thomas SK, Pradel FG, Bartlett ST. The economic impact of laparoscopic living-donor nephrectomy on kidney transplantation. Transplantation 2003; 75 (9) 1505-1512
  CrossrefPubMedGoogle Scholar
• 10 Matas AJ, Schnitzler M. Payment for living donor (vendor) kidneys: a cost-effectiveness analysis. Am J Transplant 2004; 4 (2) 216-221
  CrossrefPubMedGoogle Scholar
• 11 Smith CR, Woodward RS, Cohen DS , et al. Cadaveric versus living donor kidney transplantation: a Medicare payment analysis. Transplantation 2000; 69 (2) 311-314
  CrossrefPubMedGoogle Scholar
• 12 Matas AJ, Gillingham KJ, Elick BA , et al. Risk factors for prolonged hospitalization after kidney transplants. Clin Transplant 1997; 11 (4) 259-264
  PubMedGoogle Scholar
• 13 Johnson CP, Kuhn EM, Hariharan S, Hartz AJ, Roza AM, Adams MB. Pre-transplant identification of risk factors that adversely affect length of stay and charges for renal transplantation. Clin Transplant 1999; 13 (2) 168-175
  CrossrefPubMedGoogle Scholar
• 14 Naghibi O, Naghibi M, Nazemian F. Factors affecting length of hospitalization in kidney transplant recipients. Exp Clin Transplant 2007; 5 (1) 614-617
  PubMedGoogle Scholar
• 15 Tewari S, Kathuria A, Meier-Kriesche HU, Lansang MC. Association between admission hyperglycemia and length of stay after renal transplantation. Endocr Pract 2010; 16 (5) 805-809
  CrossrefPubMedGoogle Scholar
• 16 Matas AJ, Payne WD, Sutherland DE , et al. 2,500 living donor kidney transplants: a single-center experience. Ann Surg 2001; 234 (2) 149-164
  CrossrefPubMedGoogle Scholar
• 17 Ahmad N, Ahmed K, Khan MS , et al. Living-unrelated donor renal transplantation: an alternative to living-related donor transplantation?. Ann R Coll Surg Engl 2008; 90 (3) 247-250
  CrossrefPubMedGoogle Scholar
• 18 Woodroffe R, Yao GL, Meads C , et al. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study. Health Technol Assess 2005; 9 (21) 1-179 , iii–iv
  PubMedGoogle Scholar
• 19 Egorova NN, Gelijns AC, Moskowitz AJ , et al. Process of care events in transplantation: effects on the cost of hospitalization. Am J Transplant 2010; 10 (10) 2341-2348
  CrossrefPubMedGoogle Scholar
• 20 Holtzman J, Bjerke T, Kane R. The effects of clinical pathways for renal transplant on patient outcomes and length of stay. Med Care 1998; 36 (6) 826-834
  CrossrefPubMedGoogle Scholar
• 21 Seawright AH, Taylor L. A systematic approach to postoperative management of deceased donor kidney transplant patients with a clinical pathway. Prog Transplant 2011; 21 (1) 43-52
  PubMedGoogle Scholar
• 22 Knight MK, DiMarco DS, Myers RP , et al. Subjective and objective comparison of critical care pathways for open donor nephrectomy. J Urol 2002; 167 (6) 2368-2371
  CrossrefPubMedGoogle Scholar
• 23 Lentine KL, Schnitzler MA, Xiao H , et al. Depression diagnoses after living kidney donation: linking U.S. Registry data and administrative claims. Transplantation 2012; 94 (1) 77-83
  CrossrefPubMedGoogle Scholar